{
  "schema_version": "0.1.0",
  "case_id": "HR-BX004",
  "record_classification": {
    "synthetic": true,
    "banner": "SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD",
    "real_historical_name": true,
    "public_release_status": "draft"
  },
  "identity": {
    "person_id": "BX004",
    "display_name": "Joe Frazier",
    "aliases": [
      "Smokin' Joe"
    ],
    "sex": "male",
    "era": "Mid-Late 20th Century",
    "nationality": "American",
    "historical_dates": {
      "birth": {
        "preferred": {
          "iso": "1944-01-12",
          "display": "January 12, 1944",
          "precision": "day",
          "calendar": "gregorian"
        },
        "alternatives": [
          {
            "date": {
              "iso": "1944",
              "display": "1944",
              "precision": "year",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0008"
            ],
            "resolution_status": "preferred",
            "note": "Roster year agrees with the cited sources."
          }
        ]
      },
      "death": {
        "preferred": {
          "iso": "2011-11-07",
          "display": "November 7, 2011",
          "precision": "day",
          "calendar": "gregorian"
        },
        "alternatives": [
          {
            "date": {
              "iso": "2011",
              "display": "2011",
              "precision": "year",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0008"
            ],
            "resolution_status": "preferred",
            "note": "Roster year agrees with the cited obituaries."
          }
        ]
      }
    },
    "synthetic_identity": {
      "mrn": "HR-BX004-SYN",
      "ssn": "000-04-5590",
      "date_of_birth": "1962-01-12",
      "name_policy": "real_historical_name",
      "fictional_facility": "St. Posthumous Health Center",
      "fictional_primary_clinician": "Clarence Whitfield, MD",
      "fictional_consultant": {
        "name": "Anjali Deshpande, MD",
        "specialty": "Hepatology"
      }
    }
  },
  "historical_timeline": [
    {
      "event_id": "EVT-0001",
      "date": {
        "iso": "1944-01-12",
        "display": "January 12, 1944",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Born in Beaufort County, South Carolina.",
      "claim_ids": [
        "CLM-0001"
      ]
    },
    {
      "event_id": "EVT-0002",
      "date": {
        "iso": "1959",
        "display": "late 1950s",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Moved to Philadelphia as a teenager; worked in a slaughterhouse.",
      "claim_ids": [
        "CLM-0002"
      ]
    },
    {
      "event_id": "EVT-0003",
      "date": {
        "iso": "1964",
        "display": "1964",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Olympic heavyweight gold medal in Tokyo, with a broken left thumb; a cataract found in his left eye later that year.",
      "claim_ids": [
        "CLM-0003",
        "CLM-0004"
      ]
    },
    {
      "event_id": "EVT-0004",
      "date": {
        "iso": "1970-02-16",
        "display": "February 16, 1970",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Became undisputed heavyweight champion.",
      "claim_ids": [
        "CLM-0005"
      ]
    },
    {
      "event_id": "EVT-0005",
      "date": {
        "iso": "1975",
        "display": "1975",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Third fight of his rivalry, stopped before the fifteenth round when he could not see; vision 20/400 in the left eye.",
      "claim_ids": [
        "CLM-0004",
        "CLM-0006"
      ]
    },
    {
      "event_id": "EVT-0006",
      "date": {
        "iso": "1976",
        "display": "1976",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Retired from boxing (one further bout in 1981).",
      "claim_ids": [
        "CLM-0005"
      ]
    },
    {
      "event_id": "EVT-0007",
      "date": {
        "iso": "1996",
        "display": "1996",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Published his autobiography, Smokin' Joe.",
      "claim_ids": [
        "CLM-0011"
      ]
    },
    {
      "event_id": "EVT-0008",
      "date": {
        "iso": "2001",
        "display": "early 2000s",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Living in Philadelphia and running his gym; diabetes and high blood pressure reported publicly.",
      "claim_ids": [
        "CLM-0007",
        "CLM-0008"
      ]
    },
    {
      "event_id": "EVT-0009",
      "date": {
        "iso": "2011-10",
        "display": "October 2011",
        "precision": "month",
        "calendar": "gregorian"
      },
      "summary": "Diagnosed with liver cancer; hospice care at home in his last week.",
      "claim_ids": [
        "CLM-0009"
      ]
    },
    {
      "event_id": "EVT-0010",
      "date": {
        "iso": "2011-11-07",
        "display": "November 7, 2011",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Died in Philadelphia at 67.",
      "claim_ids": [
        "CLM-0010"
      ]
    }
  ],
  "claims": [
    {
      "claim_id": "CLM-0001",
      "statement": "Joe Frazier was born on January 12, 1944, in Beaufort County, South Carolina, the eleventh child of a sharecropping family.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "born in Beaufort, S.C., on Jan. 12, 1944"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0007",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0008",
          "relationship": "context",
          "locator": "roster birth year 1944"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0002",
      "statement": "As a teenager he moved to Philadelphia, where he had relatives, and worked in a slaughterhouse, where he punched sides of beef in the cold room.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Anchors his Philadelphia home and working life in the modern social history.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0003",
      "statement": "He won the heavyweight gold medal at the 1964 Olympic Games in Tokyo, fighting the final with a broken left thumb.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "fighting with an injured left thumb"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0007",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0004",
      "statement": "Later in 1964 he learned that he had a cataract in his left eye; visually impaired, he turned professional anyway. The cataract grew worse, and by 1975, according to his eye doctor, his vision was 20/50 in the right eye and 20/400 in the left.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Reported during his life. Anchors the reduced vision in the left eye in the modern episode. Later accounts that he hid the eye from examiners appeared only after his death and are not used.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "learned he had cataracts in his left eye; visually impaired, he turned pro"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "20/50 in the right eye and 20/400 in the left"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0005",
      "statement": "He became undisputed world heavyweight champion in February 1970 and held the title until January 1973, defending it four times; he retired in 1976 after a professional record of 32 wins, 4 losses and 1 draw, with 27 knockouts, and returned for a single bout in 1981.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Anchors a long professional career with many blows to the head, the basis for brain-health care in the modern episode.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports",
          "locator": "four successful defenses"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0006",
      "statement": "His three-fight rivalry in the 1970s included a 1971 victory that handed his opponent his first professional defeat; in the third fight, in Manila in 1975, he could no longer see, and his trainer would not let him come out for the fifteenth round.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "History only; the opponent is not named in this record.",
      "source_links": [
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "Frazier simply couldn't see"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0007",
      "statement": "In later life he lived in Philadelphia, where he owned and ran a boxing gym, and he had financial trouble.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Anchors his work at the gym and cost concerns in the modern social history.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "lives in Philadelphia, owns and runs a gym there"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "later had financial trouble and ended up running a gym"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0008",
      "statement": "During his life it was reported publicly that he had diabetes and high blood pressure.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "The anchor for the modern diabetes and hypertension; the duration, severity and treatment in the modern episode are synthetic.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "he has diabetes and high blood pressure"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0009",
      "statement": "In October 2011 he was diagnosed with liver cancer; he was in and out of the hospital from early October and received hospice care at home in his last week.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "History after the modern episode, as his manager and a family friend stated publicly. The modern episode contains no liver cancer; its teaching point is surveillance that can find liver cancer early.",
      "source_links": [
        {
          "source_id": "SRC-0005",
          "relationship": "supports",
          "locator": "diagnosed last month, his manager said; hospice treatment the last week"
        },
        {
          "source_id": "SRC-0006",
          "relationship": "supports",
          "locator": "under home hospice care"
        },
        {
          "source_id": "SRC-0007",
          "relationship": "supports",
          "locator": "hospice care after being diagnosed just over a month ago"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0010",
      "statement": "He died on November 7, 2011, in Philadelphia, at 67, after a brief illness with liver cancer.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "History only, recorded in one plain sentence.",
      "source_links": [
        {
          "source_id": "SRC-0005",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0011",
      "statement": "He published an autobiography, Smokin' Joe, in 1996.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "His nickname, used here as an alias.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "Frazier's 1996 autobiography, Smokin' Joe"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    }
  ],
  "sources": [
    {
      "source_id": "SRC-0001",
      "title": "Sielski M. Joe Frazier biography (ESPN Classic)",
      "publisher": "ESPN",
      "url": "http://www.espn.com/classic/biography/s/frazier_joe.html",
      "source_type": "biography",
      "published": null,
      "accessed": "2026-11-04",
      "rights_note": "Sports biography written during his life (it describes events through 2001); facts used with citation."
    },
    {
      "source_id": "SRC-0002",
      "title": "Diskin B. Smokin' Joe had vicious left hook (ESPN Classic)",
      "publisher": "ESPN",
      "url": "http://www.espn.com/classic/s/Frazier_joe_add.html",
      "source_type": "other",
      "published": "2003-11-19",
      "accessed": "2026-11-04",
      "rights_note": "Sports article written during his life; used for his eye doctor's reported vision figures."
    },
    {
      "source_id": "SRC-0003",
      "title": "Boxing legend Joe Frazier dies",
      "publisher": "ESPN.com news services",
      "url": "https://www.espn.com/boxing/story/_/id/7206261",
      "source_type": "other",
      "published": "2011-11-07",
      "accessed": "2026-11-04",
      "rights_note": "Obituary; facts used with citation."
    },
    {
      "source_id": "SRC-0004",
      "title": "Gelston D, Dahlberg T. Philadelphia boxing legend Joe Frazier dies (Associated Press)",
      "publisher": "The Philadelphia Inquirer",
      "url": "https://www.inquirer.com/philly/sports/boxing/Philadelphia_boxing_legend_Joe_Frazier_dies.html",
      "source_type": "other",
      "published": "2011-11-07",
      "accessed": "2026-11-04",
      "rights_note": "Wire-service obituary; facts used with citation."
    },
    {
      "source_id": "SRC-0005",
      "title": "Joe Frazier dead at 67 (Associated Press)",
      "publisher": "CBS Los Angeles",
      "url": "https://www.cbsnews.com/losangeles/news/joe-frazier-dead-at-67",
      "source_type": "other",
      "published": "2011-11-07",
      "accessed": "2026-11-04",
      "rights_note": "Wire-service obituary quoting his manager and the family's release; facts used with citation."
    },
    {
      "source_id": "SRC-0006",
      "title": "Ex-champ Frazier dies of liver cancer (Associated Press)",
      "publisher": "The Vindicator",
      "url": "https://vindyarchives.com/news/2011/nov/08/ex-champ-frazier-dies-of-liver-cancer",
      "source_type": "other",
      "published": "2011-11-08",
      "accessed": "2026-11-04",
      "rights_note": "Wire-service obituary; used for home hospice care."
    },
    {
      "source_id": "SRC-0007",
      "title": "Cancer catches Joe Frazier",
      "publisher": "The Irish Times",
      "url": "https://www.irishtimes.com/news/cancer-catches-joe-frazier-1.1285648",
      "source_type": "other",
      "published": "2011-11-08",
      "accessed": "2026-11-04",
      "rights_note": "Newspaper obituary with a dated factfile; facts used with citation."
    },
    {
      "source_id": "SRC-0008",
      "title": "HISTMED Master Roster v3",
      "publisher": "The Human Record project",
      "url": "https://humanrecord.example.org/internal/HISTMED_Master_Roster_v3.xlsx",
      "source_type": "other",
      "published": "2026-11-01",
      "accessed": "2026-11-04",
      "rights_note": "Internal source locator; inherited claims remain provisional until corroborated."
    }
  ],
  "synthetic_episode": {
    "calendar_frame": "modern_shifted",
    "index_date": "2026-02-16",
    "index_age": 64,
    "date_shift_policy": "HR-DATE-SHIFT-1",
    "teaching_objective": "Type 2 diabetes and hypertension in a 64-year-old Black man, a former professional heavyweight boxer who runs a gym, managed under the ADA Standards of Care 2026, the 2025 AHA/ACC blood pressure guideline and the CMID monographs: A1c, kidney function by the race-free CKD-EPI 2021 equation and urine albumin, lipids and a high-intensity statin, a GLP-1 receptor agonist with cardiovascular and kidney benefit, blood pressure to below 130/80 with home readings, eye and foot examinations, and cost and access. The yearly liver check finds a high FIB-4, and the AASLD 2023 MASLD guidance leads to elastography and a diagnosis of compensated cirrhosis from MASLD; under the AASLD 2023 hepatocellular carcinoma guidance he begins ultrasound with AFP every six months, the kind of surveillance that can find liver cancer early, with variceal screening, vaccines and no alcohol. Brain health in a former boxer is addressed with a documented cognitive screen and risk-factor care, and without a diagnosis of chronic traumatic encephalopathy, which can be made only after death.",
    "visit_schedule": [
      {
        "encounter_id": "ENC-001",
        "date": "2026-02-16",
        "purpose": "Establishing primary care for type 2 diabetes and high blood pressure above goal: A1c, kidney function, urine albumin, lipids, the yearly liver check with FIB-4, eyes, feet and brain health in a former professional boxer"
      },
      {
        "encounter_id": "ENC-002",
        "date": "2026-03-02",
        "purpose": "Two-week review of home blood pressure readings, with liver elastography, a liver ultrasound and the hepatology consultation"
      },
      {
        "encounter_id": "ENC-003",
        "date": "2026-04-13",
        "purpose": "Eight-week review: blood pressure, lipids, kidney function, semaglutide, the endoscopy result and vaccines"
      },
      {
        "encounter_id": "ENC-004",
        "date": "2026-05-18",
        "purpose": "Three-month review: A1c, blood pressure, weight, semaglutide dose and the eye examination"
      },
      {
        "encounter_id": "ENC-006",
        "date": "2026-07-13",
        "purpose": "Periodic adult preventive visit"
      },
      {
        "encounter_id": "ENC-005",
        "date": "2026-09-14",
        "purpose": "Seven-month review: six-month liver cancer surveillance ultrasound and AFP, A1c, kidney function, urine albumin and vaccines"
      }
    ]
  },
  "clinical": {
    "problems": [
      {
        "id": "PRB-001",
        "display": "Type 2 diabetes with hyperglycemia, about twelve years' duration, A1c 8.4% on metformin; synthetic modern episode linked to his publicly reported diabetes",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "E11.65",
            "display": "Type 2 diabetes mellitus with hyperglycemia",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic modern diagnosis; diabetes was reported publicly during his life, but its duration and treatment here are synthetic.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "both_with_link"
      },
      {
        "id": "PRB-002",
        "display": "Hypertension above goal on lisinopril (152/92 mmHg in the clinic); synthetic modern episode linked to his publicly reported high blood pressure",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "I10",
            "display": "Essential (primary) hypertension",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic modern diagnosis; high blood pressure was reported publicly during his life.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "both_with_link"
      },
      {
        "id": "PRB-003",
        "display": "Raised AST (48 U/L) with mildly low platelets (138) and a FIB-4 score of 3.43 at the yearly liver check, to be evaluated",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "R74.01",
            "display": "Elevation of levels of liver transaminase levels",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic presenting finding, superseded at the two-week visit by the elastography and ultrasound diagnosis.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "abatement_date": "2026-03-02"
      },
      {
        "id": "PRB-004",
        "display": "Metabolic dysfunction-associated steatotic liver disease (MASLD): steatosis on elastography (controlled attenuation parameter 318 dB/m) and ultrasound, with diabetes, obesity, low HDL and high triglycerides, and little alcohol",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "K76.0",
            "display": "Fatty (change of) liver, not elsewhere classified",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern diagnosis. Not part of the public record of his life; chosen to teach surveillance.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-03-02"
      },
      {
        "id": "PRB-005",
        "display": "Compensated cirrhosis (compensated advanced chronic liver disease) from MASLD: liver stiffness 17.6 kPa, platelets 138, nodular liver surface and a spleen of 13.4 cm on ultrasound; no ascites, encephalopathy, bleeding or jaundice; Child-Pugh A",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "K74.69",
            "display": "Other cirrhosis of liver",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern diagnosis. Not part of the public record of his life; the liver cancer diagnosed three years later in the true frame does not appear in the modern episode.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-03-02"
      },
      {
        "id": "PRB-006",
        "display": "Hyperlipidemia: LDL 132 mg/dL, HDL 38 and triglycerides 210, not on a statin",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "E78.5",
            "display": "Hyperlipidemia, unspecified",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic laboratory finding.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active"
      },
      {
        "id": "PRB-007",
        "display": "Obesity, class 1 (BMI 31.4)",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "E66.811",
            "display": "Obesity, class 1",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic finding; described without stigma.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active"
      },
      {
        "id": "PRB-008",
        "display": "Reduced vision in the left eye since a cataract found at 20 (counting fingers at 1 meter); right eye 20/30",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "H54.62",
            "display": "Unqualified visual loss, left eye, normal vision right eye",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004"
          ],
          "synthetic_reason": "Synthetic modern measurement anchored to the documented cataract in his left eye.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active"
      }
    ],
    "medications": [
      {
        "id": "MED-001",
        "display": "Metformin 1000 mg oral tablet, one tablet twice daily with meals; taken for years",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "861004",
            "display": "metformin hydrochloride 1000 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 12,
          "period_unit": "h",
          "text": "One tablet twice daily with meals"
        },
        "start_date": "2026-02-16",
        "indication_problem_ids": [
          "PRB-001"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic long-standing first-line diabetes medicine; continued.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "MED-002",
        "display": "Lisinopril 20 mg oral tablet, one tablet daily; taken for years",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "314077",
            "display": "lisinopril 20 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet daily"
        },
        "start_date": "2026-02-16",
        "indication_problem_ids": [
          "PRB-002"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic long-standing ACE inhibitor for hypertension with diabetes; continued.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "MED-003",
        "display": "Atorvastatin 40 mg oral tablet, one tablet daily",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "617311",
            "display": "atorvastatin 40 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet daily"
        },
        "start_date": "2026-02-16",
        "indication_problem_ids": [
          "PRB-006",
          "PRB-001"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic high-intensity statin for diabetes aged 40 to 75 with additional risk factors; safe in compensated liver disease.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "MED-004",
        "display": "Amlodipine 5 mg oral tablet, one tablet daily",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "197361",
            "display": "amlodipine 5 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet daily"
        },
        "start_date": "2026-03-02",
        "end_date": "2026-04-13",
        "indication_problem_ids": [
          "PRB-002"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic calcium channel blocker added after home readings confirmed blood pressure above goal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "MED-005",
        "display": "Amlodipine 10 mg oral tablet, one tablet daily",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "308135",
            "display": "amlodipine 10 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet daily"
        },
        "start_date": "2026-04-13",
        "indication_problem_ids": [
          "PRB-002"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic dose increase for blood pressure still above 130/80.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "MED-006",
        "display": "Semaglutide pen (0.25 mg or 0.5 mg per dose), 0.25 mg under the skin once weekly for four weeks, then 0.5 mg once weekly",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "2619152",
            "display": "0.25 MG, 0.5 MG Dose 3 ML semaglutide 0.68 MG/ML Pen Injector",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 0.5,
          "unit": "mg"
        },
        "route": "subcutaneous",
        "frequency": {
          "period": 1,
          "period_unit": "wk",
          "text": "0.25 mg weekly for four weeks, then 0.5 mg weekly"
        },
        "start_date": "2026-03-02",
        "end_date": "2026-05-18",
        "indication_problem_ids": [
          "PRB-001",
          "PRB-004",
          "PRB-007"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic GLP-1 receptor agonist with cardiovascular and kidney benefit, also helping weight and steatotic liver disease; covered after prior authorization.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "MED-007",
        "display": "Semaglutide pen (1 mg per dose), 1 mg under the skin once weekly",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "2398841",
            "display": "3 ML semaglutide 1.34 MG/ML Pen Injector",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "mg"
        },
        "route": "subcutaneous",
        "frequency": {
          "period": 1,
          "period_unit": "wk",
          "text": "1 mg once weekly"
        },
        "start_date": "2026-05-18",
        "indication_problem_ids": [
          "PRB-001",
          "PRB-004",
          "PRB-007"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic dose increase after eight weeks at 0.5 mg without side effects.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      }
    ],
    "allergies": [
      {
        "id": "ALG-001",
        "display": "No known allergy",
        "status": "active",
        "assertion": "no_known_allergy",
        "substance": {
          "system": "http://snomed.info/sct",
          "code": "716186003",
          "display": "No known allergy"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic allergy assertion for EHR completeness; not a historical assertion.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      }
    ],
    "observations": [
      {
        "id": "OBS-A1C-V1",
        "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
        "label": "Hemoglobin A1c",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-16",
        "value": 8.4,
        "unit": "%",
        "reference_range": {
          "high": 5.6,
          "text": "Below 5.7% is normal; goal below 7% for him"
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "4548-4",
            "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic A1c above goal on metformin alone.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V1",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose (fasting)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-16",
        "value": 168,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99
        },
        "interpretation": "H",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic fasting glucose.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-NA-V1",
        "display": "Sodium [Moles/volume] in Serum or Plasma",
        "label": "Sodium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-16",
        "value": 139,
        "unit": "mmol/L",
        "reference_range": {
          "low": 135,
          "high": 145
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2951-2",
            "display": "Sodium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel on lisinopril.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-K-V1",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-16",
        "value": 4.6,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel on lisinopril.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V1",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-16",
        "value": 1.08,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.74,
          "high": 1.35
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel on lisinopril.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V1",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021, no race term)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-16",
        "value": 77,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60,
          "text": "60 or higher without kidney damage markers is not CKD"
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic eGFR by CKD-EPI 2021, which has no race term.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-UACR-V1",
        "display": "Albumin/Creatinine [Mass Ratio] in Urine",
        "label": "Urine albumin-to-creatinine ratio",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-16",
        "value": 18,
        "unit": "mg/g",
        "reference_range": {
          "high": 29,
          "text": "Below 30 mg/g is normal (A1)"
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "9318-7",
            "display": "Albumin/Creatinine [Mass Ratio] in Urine",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic urine albumin-to-creatinine ratio; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-CHOL-V1",
        "display": "Cholesterol [Mass/volume] in Serum or Plasma",
        "label": "Total cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-16",
        "value": 212,
        "unit": "mg/dL",
        "reference_range": {
          "high": 199
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2093-3",
            "display": "Cholesterol [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid panel; not on a statin.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-LDL-V1",
        "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation",
        "label": "LDL cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-16",
        "value": 132,
        "unit": "mg/dL",
        "reference_range": {
          "high": 99,
          "text": "Goal below 70 mg/dL with diabetes and other risk factors"
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "13457-7",
            "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid panel; not on a statin.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-HDL-V1",
        "display": "Cholesterol in HDL [Mass/volume] in Serum or Plasma",
        "label": "HDL cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-16",
        "value": 38,
        "unit": "mg/dL",
        "reference_range": {
          "low": 40
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2085-9",
            "display": "Cholesterol in HDL [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid panel; not on a statin.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-TG-V1",
        "display": "Triglyceride [Mass/volume] in Serum or Plasma",
        "label": "Triglycerides",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-16",
        "value": 210,
        "unit": "mg/dL",
        "reference_range": {
          "high": 149
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2571-8",
            "display": "Triglyceride [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid panel; not on a statin.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-AST-V1",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-16",
        "value": 48,
        "unit": "U/L",
        "reference_range": {
          "low": 10,
          "high": 40
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic liver tests for the yearly MASLD check: AST mildly raised; liver function normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V1",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-16",
        "value": 42,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 55
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic liver tests for the yearly MASLD check: AST mildly raised; liver function normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALP-V1",
        "display": "Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "Alkaline phosphatase",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-16",
        "value": 96,
        "unit": "U/L",
        "reference_range": {
          "low": 40,
          "high": 129
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6768-6",
            "display": "Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic liver tests for the yearly MASLD check: AST mildly raised; liver function normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALB-V1",
        "display": "Albumin [Mass/volume] in Serum or Plasma",
        "label": "Albumin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-16",
        "value": 4.0,
        "unit": "g/dL",
        "reference_range": {
          "low": 3.5,
          "high": 5.0
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1751-7",
            "display": "Albumin [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic liver tests for the yearly MASLD check: AST mildly raised; liver function normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-TBIL-V1",
        "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
        "label": "Total bilirubin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-16",
        "value": 0.9,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.1,
          "high": 1.2
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1975-2",
            "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic liver tests for the yearly MASLD check: AST mildly raised; liver function normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V1",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-16",
        "value": 14.2,
        "unit": "g/dL",
        "reference_range": {
          "low": 13.5,
          "high": 17.5
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic hemoglobin; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V1",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-16",
        "value": 138,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic platelets, mildly low; with age and AST gives a high FIB-4.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-B12-V1",
        "display": "Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma",
        "label": "Vitamin B12",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-16",
        "value": 340,
        "unit": "pg/mL",
        "reference_range": {
          "low": 232,
          "high": 1245
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2132-9",
            "display": "Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vitamin B12 on long-term metformin; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V1",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-02-16",
        "value": 4,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic depression screen; minimal symptoms. Not a claim about his real mood.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-AUDITC-V1",
        "display": "Total score [AUDIT-C]",
        "label": "AUDIT-C",
        "status": "final",
        "effective_date": "2026-02-16",
        "value": 2,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "75626-2",
            "display": "Total score [AUDIT-C]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic alcohol screen; low risk.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-LSM-V2",
        "display": "Liver stiffness by US.transient elastography",
        "label": "Liver stiffness (transient elastography)",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-03-02",
        "value": 17.6,
        "unit": "kPa",
        "reference_range": {
          "high": 7.9,
          "text": "Below 8 kPa makes advanced fibrosis unlikely; 15 kPa or higher is consistent with compensated advanced chronic liver disease"
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "77615-3",
            "display": "Liver stiffness by US.transient elastography",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic liver stiffness by transient elastography, consistent with compensated advanced chronic liver disease; controlled attenuation parameter 318 dB/m (steatosis), reported in the note text.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-INR-V2",
        "display": "INR in Platelet poor plasma by Coagulation assay",
        "label": "INR",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-02",
        "value": 1.1,
        "unit": "{INR}",
        "reference_range": {
          "low": 0.8,
          "high": 1.2
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6301-6",
            "display": "INR in Platelet poor plasma by Coagulation assay",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic INR; normal liver synthetic function.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-AFP-V2",
        "display": "Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma",
        "label": "Alpha-fetoprotein (AFP)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-02",
        "value": 4.2,
        "unit": "ng/mL",
        "reference_range": {
          "high": 8.3
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1834-1",
            "display": "Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic AFP with the first surveillance ultrasound; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-K-V3",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-13",
        "value": 4.7,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic potassium and creatinine; stable.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V3",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-13",
        "value": 1.1,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.74,
          "high": 1.35
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic potassium and creatinine; stable.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V3",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021, no race term)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-13",
        "value": 75,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60,
          "text": "60 or higher without kidney damage markers is not CKD"
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic eGFR; stable.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-CHOL-V3",
        "display": "Cholesterol [Mass/volume] in Serum or Plasma",
        "label": "Total cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-13",
        "value": 148,
        "unit": "mg/dL",
        "reference_range": {
          "high": 199
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2093-3",
            "display": "Cholesterol [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid panel eight weeks after starting atorvastatin.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-LDL-V3",
        "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation",
        "label": "LDL cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-13",
        "value": 68,
        "unit": "mg/dL",
        "reference_range": {
          "high": 99,
          "text": "Goal below 70 mg/dL with diabetes and other risk factors"
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "13457-7",
            "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid panel eight weeks after starting atorvastatin.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-HDL-V3",
        "display": "Cholesterol in HDL [Mass/volume] in Serum or Plasma",
        "label": "HDL cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-13",
        "value": 40,
        "unit": "mg/dL",
        "reference_range": {
          "low": 40
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2085-9",
            "display": "Cholesterol in HDL [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid panel eight weeks after starting atorvastatin.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-TG-V3",
        "display": "Triglyceride [Mass/volume] in Serum or Plasma",
        "label": "Triglycerides",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-13",
        "value": 168,
        "unit": "mg/dL",
        "reference_range": {
          "high": 149
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2571-8",
            "display": "Triglyceride [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid panel eight weeks after starting atorvastatin.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-AST-V3",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-13",
        "value": 44,
        "unit": "U/L",
        "reference_range": {
          "low": 10,
          "high": 40
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic AST and ALT on atorvastatin; not higher.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V3",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-13",
        "value": 40,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 55
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic AST and ALT on atorvastatin; not higher.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-A1C-V4",
        "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
        "label": "Hemoglobin A1c",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-18",
        "value": 7.3,
        "unit": "%",
        "reference_range": {
          "high": 5.6,
          "text": "Below 5.7% is normal; goal below 7% for him"
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "4548-4",
            "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic A1c three months after intake, eleven weeks after starting semaglutide.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ2-V6",
        "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
        "label": "PHQ-2",
        "status": "final",
        "effective_date": "2026-07-13",
        "value": 1,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "55758-7",
            "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-2 at the preventive visit; negative.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-MOCA-V6",
        "display": "Total score [MoCA]",
        "label": "MoCA",
        "status": "final",
        "effective_date": "2026-07-13",
        "value": 26,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "72172-0",
            "display": "Total score [MoCA]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic Montreal Cognitive Assessment, education-adjusted; within the normal range. Not a claim about his real cognition.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-A1C-V5",
        "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
        "label": "Hemoglobin A1c",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-14",
        "value": 6.8,
        "unit": "%",
        "reference_range": {
          "high": 5.6,
          "text": "Below 5.7% is normal; goal below 7% for him"
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "4548-4",
            "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic A1c at goal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-NA-V5",
        "display": "Sodium [Moles/volume] in Serum or Plasma",
        "label": "Sodium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-14",
        "value": 140,
        "unit": "mmol/L",
        "reference_range": {
          "low": 135,
          "high": 145
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2951-2",
            "display": "Sodium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel; stable.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-K-V5",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-14",
        "value": 4.5,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel; stable.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V5",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-14",
        "value": 1.06,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.74,
          "high": 1.35
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel; stable.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V5",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021, no race term)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-14",
        "value": 78,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60,
          "text": "60 or higher without kidney damage markers is not CKD"
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic eGFR; stable.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-UACR-V5",
        "display": "Albumin/Creatinine [Mass Ratio] in Urine",
        "label": "Urine albumin-to-creatinine ratio",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-14",
        "value": 14,
        "unit": "mg/g",
        "reference_range": {
          "high": 29,
          "text": "Below 30 mg/g is normal (A1)"
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "9318-7",
            "display": "Albumin/Creatinine [Mass Ratio] in Urine",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic urine albumin-to-creatinine ratio; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-AST-V5",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-14",
        "value": 38,
        "unit": "U/L",
        "reference_range": {
          "low": 10,
          "high": 40
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic liver tests after 6.5% weight loss; AST normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V5",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-14",
        "value": 31,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 55
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic liver tests after 6.5% weight loss; AST normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALB-V5",
        "display": "Albumin [Mass/volume] in Serum or Plasma",
        "label": "Albumin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-14",
        "value": 4.1,
        "unit": "g/dL",
        "reference_range": {
          "low": 3.5,
          "high": 5.0
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1751-7",
            "display": "Albumin [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic liver tests after 6.5% weight loss; AST normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-TBIL-V5",
        "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
        "label": "Total bilirubin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-14",
        "value": 0.8,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.1,
          "high": 1.2
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1975-2",
            "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic liver tests after 6.5% weight loss; AST normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V5",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-14",
        "value": 140,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic platelets; stable.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "OBS-AFP-V5",
        "display": "Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma",
        "label": "Alpha-fetoprotein (AFP)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-14",
        "value": 4.0,
        "unit": "ng/mL",
        "reference_range": {
          "high": 8.3
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1834-1",
            "display": "Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic AFP with the six-month surveillance ultrasound; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      }
    ],
    "procedures": [
      {
        "id": "PROC-001",
        "display": "Twelve-lead electrocardiogram",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "29303009",
            "display": "Electrocardiographic procedure",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-02-16",
          "end": "2026-02-16"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline ECG for hypertension and diabetes: sinus rhythm at 76, normal intervals, no left ventricular hypertrophy and no Q waves (reported in the note text).",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "PROC-002",
        "display": "Comprehensive diabetic foot examination with a 10-g monofilament, vibration and pulses",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "401191002",
            "display": "Diabetic foot examination",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-02-16",
          "end": "2026-02-16"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic foot examination: protective sensation intact, vibration slightly reduced at both great toes, pulses present, callus under both forefeet (reported in the note text).",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "PROC-003",
        "display": "Liver transient elastography with controlled attenuation parameter",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "441491005",
            "display": "Ultrasound elastography of liver",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-03-02",
          "end": "2026-03-02"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic elastography: median liver stiffness 17.6 kPa (interquartile range 14%), controlled attenuation parameter 318 dB/m (reported in the note text).",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "PROC-004",
        "display": "Liver ultrasound for hepatocellular carcinoma surveillance, baseline",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "718290002",
            "display": "Ultrasonography of liver for early detection of hepatocellular carcinoma",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-03-02",
          "end": "2026-03-02"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic ultrasound: coarse, echogenic liver with a mildly nodular surface, spleen 13.4 cm, patent portal vein, no ascites and no focal liver lesion; visualization score A (reported in the note text).",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "PROC-005",
        "display": "Upper endoscopy to screen for varices",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "76009000",
            "display": "Esophagogastroduodenoscopy",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-04-06",
          "end": "2026-04-06"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic endoscopy: no esophageal or gastric varices; mild portal hypertensive gastropathy absent (reported in the note text).",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "PROC-006",
        "display": "Dilated eye examination at the eye clinic",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "410451008",
            "display": "Indirect ophthalmoscopy",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-06-22",
          "end": "2026-06-22"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004"
          ],
          "synthetic_reason": "Synthetic dilated examination after a missed appointment: no diabetic retinopathy in the right eye; left eye view hazy from old lens changes, no retinopathy seen (reported in the note text).",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "PROC-007",
        "display": "Liver ultrasound for hepatocellular carcinoma surveillance, six months",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "718290002",
            "display": "Ultrasonography of liver for early detection of hepatocellular carcinoma",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-09-14",
          "end": "2026-09-14"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic six-month surveillance ultrasound: unchanged nodular surface, no focal liver lesion, no ascites; visualization score A (reported in the note text).",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "PROC-008",
        "display": "Advance care planning conversation, about 18 minutes",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "713603004",
            "display": "Advance care planning",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-07-13",
          "end": "2026-07-13"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic voluntary advance care planning at the preventive visit; no specific treatment preference is recorded.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      }
    ],
    "immunizations": [
      {
        "id": "IMM-001",
        "display": "Tdap vaccine",
        "status": "completed",
        "date": "2026-02-16",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "115",
            "display": "Tdap",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic booster; none recorded in ten years.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "IMM-002",
        "display": "Pneumococcal conjugate vaccine PCV20",
        "status": "completed",
        "date": "2026-03-02",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "216",
            "display": "Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic single dose for an adult with diabetes and chronic liver disease.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "IMM-003",
        "display": "Hepatitis B vaccine (HepB-CpG), dose 1 of 2",
        "status": "completed",
        "date": "2026-03-02",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "189",
            "display": "HepB-CpG",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vaccination for an adult with diabetes and chronic liver disease who is not immune.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "IMM-004",
        "display": "Hepatitis A vaccine, adult, dose 1 of 2",
        "status": "completed",
        "date": "2026-03-02",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "52",
            "display": "Hep A, adult",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vaccination for chronic liver disease; not immune.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "IMM-005",
        "display": "Hepatitis B vaccine (HepB-CpG), dose 2 of 2",
        "status": "completed",
        "date": "2026-04-13",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "189",
            "display": "HepB-CpG",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic second dose, at least four weeks after the first.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "IMM-006",
        "display": "Hepatitis A vaccine, adult, dose 2 of 2",
        "status": "completed",
        "date": "2026-09-14",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "52",
            "display": "Hep A, adult",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic second dose six months after the first.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "IMM-007",
        "display": "Recombinant zoster vaccine, dose 1 of 2",
        "status": "completed",
        "date": "2026-07-13",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "187",
            "display": "zoster recombinant",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic first dose for an adult over 50.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "IMM-008",
        "display": "Recombinant zoster vaccine, dose 2 of 2",
        "status": "completed",
        "date": "2026-09-14",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "187",
            "display": "zoster recombinant",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic second dose two months after the first.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "IMM-009",
        "display": "Influenza vaccine, inactivated, this season",
        "status": "completed",
        "date": "2026-09-14",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "140",
            "display": "Influenza, split virus, trivalent, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seasonal influenza vaccination.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "IMM-010",
        "display": "COVID-19 vaccine, mRNA, this season",
        "status": "completed",
        "date": "2026-09-14",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "309",
            "display": "COVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mL",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seasonal COVID-19 vaccination.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "IMM-011",
        "display": "RSV vaccine, single dose",
        "status": "completed",
        "date": "2026-09-14",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "305",
            "display": "RSV, bivalent, protein subunit RSVpreF, diluent reconstituted, 0.5 mL, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic single RSV dose for an adult aged 60 to 74 with diabetes and chronic liver disease.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      }
    ],
    "family_history": [],
    "past_medical_history": [
      {
        "id": "PMH-001",
        "display": "Broken left thumb in the 1964 Olympic final",
        "historical_date": {
          "iso": "1964",
          "display": "1964",
          "precision": "year",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0003"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "PMH-002",
        "display": "Cataract in the left eye found at 20, with reduced vision in that eye through his boxing career (20/400 in that eye by 1975)",
        "historical_date": {
          "iso": "1964",
          "display": "1964",
          "precision": "year",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0004"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "PMH-003",
        "display": "Professional heavyweight boxing career with many blows to the head, including a 1975 bout stopped when he could no longer see",
        "historical_date": {
          "iso": "1965",
          "display": "1965 to 1976, and one bout in 1981",
          "precision": "year",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0005",
            "CLM-0006"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "PMH-004",
        "display": "Diabetes and high blood pressure, reported publicly",
        "historical_date": {
          "iso": "2001",
          "display": "early 2000s",
          "precision": "year",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      }
    ],
    "encounters": [
      {
        "id": "ENC-001",
        "display": "Establishing primary care for type 2 diabetes and high blood pressure above goal: A1c, kidney function, urine albumin, lipids, the yearly liver check with FIB-4, eyes, feet and brain health in a former professional boxer",
        "status": "finished",
        "date": "2026-02-16",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "ENC-002",
        "display": "Two-week review of home blood pressure readings, with liver elastography, a liver ultrasound and the hepatology consultation",
        "status": "finished",
        "date": "2026-03-02",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "Two-week review of home blood pressure readings, with liver elastography, ultrasound and hepatology",
          "hpi": {
            "narrative": "Mr. Frazier returns two weeks after intake with a week of home blood pressure readings, twice a day, averaging 146/90. He is taking metformin, lisinopril and the new atorvastatin without trouble. This morning he had liver elastography and a liver ultrasound, and he saw Dr. Deshpande of hepatology. He has had no swelling of the legs or abdomen, no black stools, no confusion and no yellowing. He drinks one or two beers on some weekends and agreed today to stop. He asked what a scarred liver means for his work at the gym.",
            "elements": [
              {
                "label": "Home blood pressure",
                "value": "Average 146/90 over seven days"
              },
              {
                "label": "Atorvastatin",
                "value": "Two weeks; no muscle aches"
              },
              {
                "label": "Liver symptoms",
                "value": "None"
              },
              {
                "label": "Alcohol",
                "value": "Agreed to stop"
              }
            ]
          },
          "ros": [
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "No abdominal swelling, black stools or vomiting of blood"
            },
            {
              "system": "Musculoskeletal",
              "status": "negative",
              "finding": "No muscle aches on atorvastatin"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No confusion or day-night reversal"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; blood pressure 148/90, pulse 74; weight 103.6 kg"
            },
            {
              "system": "Abdomen",
              "finding": "Soft; liver edge firm at the costal margin; spleen tip not felt; no ascites"
            },
            {
              "system": "Skin",
              "finding": "No jaundice, spider angiomas or palmar erythema"
            },
            {
              "system": "Neurological",
              "finding": "No asterixis"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-005",
              "display": "Compensated cirrhosis from MASLD",
              "assessment": "Liver stiffness 17.6 kPa with a controlled attenuation parameter of 318 dB/m; ultrasound shows a mildly nodular liver, a spleen of 13.4 cm and no focal lesion; AFP 4.2 ng/mL; INR 1.1; albumin 4.0 g/dL; bilirubin 0.9 mg/dL; platelets 138. Child-Pugh A (5 points), MELD 8. Hepatitis B surface antigen, core antibody and surface antibody negative; hepatitis A antibody negative; hepatitis C antibody and HIV test nonreactive; iron studies and autoimmune tests normal. Dr. Deshpande agrees this is compensated cirrhosis from MASLD, with little alcohol",
              "plan": [
                "Liver ultrasound with AFP every six months; the next in September",
                "Upper endoscopy to screen for varices, because platelets below 150 and a stiffness of 17.6 kPa cannot rule out portal hypertension",
                "No alcohol; no ibuprofen or naproxen; acetaminophen no more than 2 g a day",
                "PCV20 and first doses of hepatitis A and B vaccines today"
              ]
            },
            {
              "problem_id": "PRB-001",
              "display": "Type 2 diabetes, A1c 8.4%",
              "assessment": "Above goal on metformin. A GLP-1 receptor agonist adds cardiovascular and kidney benefit and helps weight and steatotic liver disease; it is safe in compensated cirrhosis. Coverage approved after prior authorization",
              "plan": [
                "Start semaglutide 0.25 mg weekly for four weeks, then 0.5 mg weekly",
                "Continue metformin, safe with normal kidney function and compensated cirrhosis",
                "Diabetes self-management class booked"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Hypertension",
              "assessment": "Home average 146/90 confirms blood pressure above the goal of 130/80 on lisinopril",
              "plan": [
                "Add amlodipine 5 mg daily",
                "Home readings twice a day for a week before the next visit"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "examination",
              "measure": "Blood pressure (clinic and home), weight and BMI",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "148/90 in the clinic; home average 146/90; weight 103.6 kg",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-AHA-HTN-2025"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Hemoglobin A1c",
              "cadence": "Every 3 months until at goal or after a change in treatment, then every 6 months",
              "status": "up_to_date",
              "detail": "8.4% two weeks ago; next in three months",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-ADA-PHARM-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Low blood sugar review and medicine tolerability",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No low blood sugar; metformin tolerated",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-ADA-PHARM-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Lipid panel",
              "cadence": "4 to 12 weeks after starting a statin, then yearly",
              "status": "up_to_date",
              "detail": "Atorvastatin started two weeks ago; lipids at eight weeks",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-ADA-CVD-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Potassium, creatinine and eGFR (CKD-EPI 2021) on lisinopril",
              "cadence": "Every 6 months on an ACE inhibitor, and after changes",
              "status": "up_to_date",
              "detail": "Potassium 4.6, creatinine 1.08 mg/dL, eGFR 77 two weeks ago",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-ADA-CKD-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Urine albumin-to-creatinine ratio",
              "cadence": "Yearly",
              "status": "up_to_date",
              "detail": "18 mg/g two weeks ago",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-ADA-CKD-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Liver tests with FIB-4",
              "cadence": "Yearly with diabetes; FIB-4 1.3 or higher leads to elastography",
              "status": "up_to_date",
              "detail": "FIB-4 3.43 two weeks ago (age 64, AST 48, ALT 42, platelets 138): high risk",
              "guideline_ids": [
                "GL-AASLD-MASLD-2023",
                "GL-ADA-COMORB-2026"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Transient elastography",
              "cadence": "When FIB-4 is 1.3 or higher; repeat in 1 to 2 years",
              "status": "completed_today",
              "detail": "Liver stiffness 17.6 kPa; controlled attenuation parameter 318 dB/m",
              "observation_ids": [
                "OBS-LSM-V2"
              ],
              "guideline_ids": [
                "GL-AASLD-MASLD-2023",
                "GL-ADA-COMORB-2026"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Liver ultrasound with AFP for hepatocellular carcinoma surveillance",
              "cadence": "Every 6 months in cirrhosis",
              "status": "completed_today",
              "detail": "Baseline ultrasound without a focal lesion; AFP 4.2 ng/mL",
              "observation_ids": [
                "OBS-AFP-V2"
              ],
              "guideline_ids": [
                "GL-AASLD-HCC-2023"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Liver function (albumin, bilirubin, INR, platelets; Child-Pugh and MELD)",
              "cadence": "At diagnosis, then every 6 months",
              "status": "completed_today",
              "detail": "INR 1.1, albumin 4.0, bilirubin 0.9, platelets 138; Child-Pugh A5, MELD 8",
              "observation_ids": [
                "OBS-INR-V2"
              ],
              "guideline_ids": [
                "GL-AASLD-HCC-2023",
                "GL-BAVENO-VII"
              ]
            },
            {
              "domain": "referral",
              "measure": "Variceal screening",
              "cadence": "Endoscopy when portal hypertension cannot be ruled out; repeat in 2 years if no varices and the liver injury continues",
              "status": "ordered",
              "detail": "Upper endoscopy booked for next month",
              "guideline_ids": [
                "GL-BAVENO-VII"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Alcohol abstinence",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Agreed to stop the occasional beer",
              "guideline_ids": [
                "GL-AASLD-MASLD-2023",
                "GL-ADA-COMORB-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "No NSAIDs; acetaminophen no more than 2 g a day",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Explained; he uses no pain medicine now",
              "guideline_ids": [
                "GL-AASLD-MASLD-2023",
                "GL-ADA-COMORB-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Vaccines for diabetes and chronic liver disease",
              "cadence": "At diagnosis of chronic liver disease",
              "status": "completed_today",
              "detail": "PCV20 and first doses of hepatitis A and B vaccines today",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "domain": "referral",
              "measure": "Hepatology consultation",
              "cadence": "At diagnosis of advanced fibrosis or cirrhosis",
              "status": "completed_today",
              "detail": "Seen by Dr. Deshpande today",
              "guideline_ids": [
                "GL-AASLD-MASLD-2023",
                "GL-ADA-COMORB-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Medicine cost and coverage",
              "cadence": "With each new medicine",
              "status": "completed_today",
              "detail": "Semaglutide approved after prior authorization; generics for the rest",
              "guideline_ids": [
                "GL-ADA-POP-2026"
              ]
            }
          ],
          "follow_up": "Endoscopy next month. Visit in six weeks with lipids, potassium, creatinine and home readings. Diabetes class",
          "guideline_ids": [
            "GL-AASLD-MASLD-2023",
            "GL-AASLD-HCC-2023",
            "GL-BAVENO-VII",
            "GL-ADA-PHARM-2026",
            "GL-ADA-COMORB-2026",
            "GL-AHA-HTN-2025",
            "GL-CDC-IMZ-2026",
            "GL-CMID-2026"
          ]
        }
      },
      {
        "id": "ENC-003",
        "display": "Eight-week review: blood pressure, lipids, kidney function, semaglutide, the endoscopy result and vaccines",
        "status": "finished",
        "date": "2026-04-13",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "Eight-week review: blood pressure, lipids, kidney function, semaglutide and the endoscopy result",
          "hpi": {
            "narrative": "Mr. Frazier returns six weeks after the consultation. He took semaglutide 0.25 mg weekly for four weeks and has taken 0.5 mg for two weeks; he had mild nausea for two days after each step and none now, and no abdominal pain. His appetite is smaller and he has lost 1.8 kg. He takes amlodipine 5 mg; home readings average 136/84. He has had no alcohol. The upper endoscopy last week showed no varices. He attended the first diabetes class. His eye appointment is next month.",
            "elements": [
              {
                "label": "Semaglutide",
                "value": "0.25 mg for four weeks, 0.5 mg for two weeks; mild nausea after each step, now gone"
              },
              {
                "label": "Home blood pressure",
                "value": "Average 136/84 on amlodipine 5 mg"
              },
              {
                "label": "Endoscopy",
                "value": "No varices"
              },
              {
                "label": "Alcohol",
                "value": "None"
              }
            ]
          },
          "ros": [
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "Nausea after each dose step, now gone; no abdominal pain, vomiting or black stools"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No ankle swelling or chest pain"
            },
            {
              "system": "Musculoskeletal",
              "status": "negative",
              "finding": "No muscle aches"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; blood pressure 134/82, pulse 72; weight 101.8 kg"
            },
            {
              "system": "Cardiovascular",
              "finding": "No ankle edema"
            },
            {
              "system": "Abdomen",
              "finding": "Soft and non-tender; no ascites"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-002",
              "display": "Hypertension",
              "assessment": "Improved but still above 130/80 in the clinic and at home. Potassium 4.7 and creatinine 1.10 mg/dL (eGFR 75), stable on lisinopril",
              "plan": [
                "Increase amlodipine to 10 mg daily",
                "Tell us about any ankle swelling"
              ]
            },
            {
              "problem_id": "PRB-006",
              "display": "Hyperlipidemia on atorvastatin",
              "assessment": "LDL 68 mg/dL from 132 at eight weeks; AST 44 and ALT 40 U/L, not higher on the statin",
              "plan": [
                "Continue atorvastatin 40 mg; lipids yearly"
              ]
            },
            {
              "problem_id": "PRB-005",
              "display": "Compensated cirrhosis from MASLD",
              "assessment": "No varices on endoscopy, so no beta-blocker is needed for that purpose; with the liver injury ongoing, the endoscopy should be repeated in two years",
              "plan": [
                "Repeat endoscopy in two years",
                "Second hepatitis B vaccine today",
                "Next surveillance ultrasound with AFP in September"
              ]
            },
            {
              "problem_id": "PRB-001",
              "display": "Type 2 diabetes",
              "assessment": "Tolerating semaglutide; weight down 2.2 kg since intake",
              "plan": [
                "Continue semaglutide 0.5 mg weekly; consider 1 mg at the three-month visit",
                "A1c in five weeks"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "examination",
              "measure": "Blood pressure (clinic and home), weight and BMI",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "134/82 in the clinic; home average 136/84; weight 101.8 kg",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-AHA-HTN-2025"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Potassium, creatinine and eGFR (CKD-EPI 2021) on lisinopril",
              "cadence": "Every 6 months on an ACE inhibitor, and after changes",
              "status": "completed_today",
              "detail": "Potassium 4.7, creatinine 1.10 mg/dL, eGFR 75",
              "observation_ids": [
                "OBS-K-V3",
                "OBS-CR-V3",
                "OBS-EGFR-V3"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-ADA-CKD-2026",
                "GL-CMID-2026",
                "GL-AHA-HTN-2025"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Lipid panel",
              "cadence": "4 to 12 weeks after starting a statin, then yearly",
              "status": "completed_today",
              "detail": "Total 148, LDL 68, HDL 40, triglycerides 168 mg/dL",
              "observation_ids": [
                "OBS-CHOL-V3",
                "OBS-LDL-V3",
                "OBS-HDL-V3",
                "OBS-TG-V3"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-ADA-CVD-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Liver tests with FIB-4",
              "cadence": "With statin start and yearly",
              "status": "completed_today",
              "detail": "AST 44, ALT 40 U/L",
              "observation_ids": [
                "OBS-AST-V3",
                "OBS-ALT-V3"
              ],
              "guideline_ids": [
                "GL-AASLD-MASLD-2023",
                "GL-ADA-COMORB-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Hemoglobin A1c",
              "cadence": "Every 3 months until at goal or after a change in treatment, then every 6 months",
              "status": "due",
              "detail": "Due at three months, in five weeks",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-ADA-PHARM-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Semaglutide dose steps, nausea, abdominal pain, gallbladder and pancreatitis symptoms",
              "cadence": "At each dose step",
              "status": "completed_today",
              "detail": "0.5 mg weekly; transient nausea; no abdominal pain",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-ADA-PHARM-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Low blood sugar review and medicine tolerability",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No low blood sugar",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-ADA-PHARM-2026"
              ]
            },
            {
              "domain": "referral",
              "measure": "Variceal screening",
              "cadence": "Endoscopy when portal hypertension cannot be ruled out; repeat in 2 years if no varices and the liver injury continues",
              "status": "completed_today",
              "detail": "Endoscopy last week: no varices; repeat in two years",
              "guideline_ids": [
                "GL-BAVENO-VII"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Liver ultrasound with AFP for hepatocellular carcinoma surveillance",
              "cadence": "Every 6 months in cirrhosis",
              "status": "up_to_date",
              "detail": "Baseline in March; next in September",
              "guideline_ids": [
                "GL-AASLD-HCC-2023"
              ]
            },
            {
              "domain": "examination",
              "measure": "Dilated eye examination",
              "cadence": "At the start of care, then every 1 to 2 years; promptly when A1c is falling quickly on a GLP-1 receptor agonist",
              "status": "ordered",
              "detail": "Eye clinic appointment next month",
              "guideline_ids": [
                "GL-ADA-RETFOOT-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Alcohol abstinence",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No alcohol",
              "guideline_ids": [
                "GL-AASLD-MASLD-2023",
                "GL-ADA-COMORB-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Diabetes self-management education",
              "cadence": "At the start of care and yearly",
              "status": "completed_today",
              "detail": "First class attended",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-ADA-PHARM-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Vaccines for diabetes and chronic liver disease",
              "cadence": "At diagnosis of chronic liver disease",
              "status": "completed_today",
              "detail": "Hepatitis B dose 2 today; hepatitis A dose 2 in September",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            }
          ],
          "follow_up": "Three-month review in five weeks with the A1c and home readings. Eye clinic next month",
          "guideline_ids": [
            "GL-AHA-HTN-2025",
            "GL-ADA-CVD-2026",
            "GL-ADA-CKD-2026",
            "GL-ADA-PHARM-2026",
            "GL-BAVENO-VII",
            "GL-AASLD-HCC-2023",
            "GL-CDC-IMZ-2026",
            "GL-CMID-2026"
          ]
        }
      },
      {
        "id": "ENC-004",
        "display": "Three-month review: A1c, blood pressure, weight, semaglutide dose and the eye examination",
        "status": "finished",
        "date": "2026-05-18",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "Three-month review: A1c, blood pressure, weight and semaglutide dose",
          "hpi": {
            "narrative": "Mr. Frazier returns five weeks after his eight-week review. He has taken semaglutide 0.5 mg weekly for seven weeks without nausea. He takes amlodipine 10 mg; home readings average 128/78, and he has no ankle swelling. He has had no alcohol. He has lost 4.1 kg since intake. He missed his eye clinic appointment because it fell on the evening of a fight card at his gym, and it has not yet been rebooked.",
            "elements": [
              {
                "label": "Semaglutide",
                "value": "0.5 mg weekly for seven weeks; no side effects"
              },
              {
                "label": "Home blood pressure",
                "value": "Average 128/78 on amlodipine 10 mg"
              },
              {
                "label": "Weight",
                "value": "99.9 kg, down 4.1 kg"
              },
              {
                "label": "Eye examination",
                "value": "Missed; not rebooked"
              }
            ]
          },
          "ros": [
            {
              "system": "Eyes",
              "status": "negative",
              "finding": "No new blurring or floaters in the right eye"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "No nausea or abdominal pain"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No ankle swelling"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; blood pressure 126/78, pulse 74; weight 99.9 kg, BMI 30.2"
            },
            {
              "system": "Cardiovascular",
              "finding": "No ankle edema"
            },
            {
              "system": "Abdomen",
              "finding": "Soft; no ascites"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-001",
              "display": "Type 2 diabetes",
              "assessment": "A1c 7.3% from 8.4%; no low blood sugar. The dilated eye examination planned at intake has not happened; it matters more now because a rapid fall in A1c on a GLP-1 receptor agonist can briefly worsen existing diabetic retinopathy. He has no new eye symptoms",
              "plan": [
                "Increase semaglutide to 1 mg weekly",
                "Eye clinic appointment rebooked by the clinic on a day he chose, with a reminder call"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Hypertension",
              "assessment": "At goal: 126/78 in the clinic and 128/78 at home",
              "plan": [
                "Continue lisinopril 20 mg and amlodipine 10 mg"
              ]
            },
            {
              "problem_id": "PRB-007",
              "display": "Obesity",
              "assessment": "4% weight loss; the goal for the liver is 7 to 10%",
              "plan": [
                "Continue smaller portions, less salt and walks after dinner"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "laboratory",
              "measure": "Hemoglobin A1c",
              "cadence": "Every 3 months until at goal or after a change in treatment, then every 6 months",
              "status": "completed_today",
              "detail": "7.3% from 8.4%",
              "observation_ids": [
                "OBS-A1C-V4"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-ADA-PHARM-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Blood pressure (clinic and home), weight and BMI",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "126/78 in the clinic; home average 128/78; weight 99.9 kg",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-AHA-HTN-2025"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Semaglutide dose steps, nausea, abdominal pain, gallbladder and pancreatitis symptoms",
              "cadence": "At each dose step",
              "status": "completed_today",
              "detail": "0.5 mg for seven weeks without side effects; increased to 1 mg",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-ADA-PHARM-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Low blood sugar review and medicine tolerability",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No low blood sugar",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-ADA-PHARM-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Dilated eye examination",
              "cadence": "At the start of care, then every 1 to 2 years; promptly when A1c is falling quickly on a GLP-1 receptor agonist",
              "status": "deferred",
              "detail": "Planned at intake but not done three months later: he missed the appointment, and it was not rebooked. No harm is known: he has no new eye symptoms, and the later examination found no retinopathy. Corrective action: the clinic rebooked it on a day he chose, with a reminder call, before the A1c falls further",
              "guideline_ids": [
                "GL-ADA-RETFOOT-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Potassium, creatinine and eGFR (CKD-EPI 2021) on lisinopril",
              "cadence": "Every 6 months on an ACE inhibitor, and after changes",
              "status": "up_to_date",
              "detail": "Stable five weeks ago; next at seven months",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-ADA-CKD-2026"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Liver ultrasound with AFP for hepatocellular carcinoma surveillance",
              "cadence": "Every 6 months in cirrhosis",
              "status": "up_to_date",
              "detail": "Next in September",
              "guideline_ids": [
                "GL-AASLD-HCC-2023"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Weight loss of 7 to 10%",
              "cadence": "Each visit",
              "status": "completed_today",
              "detail": "4% so far",
              "guideline_ids": [
                "GL-AASLD-MASLD-2023",
                "GL-ADA-COMORB-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Alcohol abstinence",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No alcohol",
              "guideline_ids": [
                "GL-AASLD-MASLD-2023",
                "GL-ADA-COMORB-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Diabetes self-management education",
              "cadence": "At the start of care and yearly",
              "status": "completed_today",
              "detail": "Series of classes completed",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-ADA-PHARM-2026"
              ]
            }
          ],
          "follow_up": "Eye clinic next month. Preventive visit in eight weeks. Seven-month review in September with the surveillance ultrasound and AFP",
          "guideline_ids": [
            "GL-ADA-PHARM-2026",
            "GL-ADA-RETFOOT-2026",
            "GL-AHA-HTN-2025",
            "GL-AASLD-MASLD-2023",
            "GL-AASLD-HCC-2023",
            "GL-CMID-2026"
          ]
        }
      },
      {
        "id": "ENC-005",
        "display": "Seven-month review: six-month liver cancer surveillance ultrasound and AFP, A1c, kidney function, urine albumin and vaccines",
        "status": "finished",
        "date": "2026-09-14",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "Seven-month review with the six-month liver cancer surveillance ultrasound and AFP",
          "hpi": {
            "narrative": "Mr. Frazier returns nine weeks after his preventive visit. He has taken semaglutide 1 mg weekly for four months, with metformin, lisinopril, amlodipine and atorvastatin, without missed doses or side effects. Home readings average 124/78. He has had no alcohol since March. He has lost 6.8 kg since intake. He had the six-month liver ultrasound this morning. His PSA from the preventive visit was 1.4 ng/mL, which he was told by phone, and his colonoscopy is booked for next month. He has had no leg or abdominal swelling, black stools, confusion or yellowing.",
            "elements": [
              {
                "label": "Semaglutide",
                "value": "1 mg weekly for four months"
              },
              {
                "label": "Home blood pressure",
                "value": "Average 124/78"
              },
              {
                "label": "Weight",
                "value": "97.2 kg, down 6.8 kg (6.5%)"
              },
              {
                "label": "Alcohol",
                "value": "None since March"
              },
              {
                "label": "Screening",
                "value": "PSA 1.4 ng/mL; colonoscopy next month"
              }
            ]
          },
          "ros": [
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "No abdominal swelling, black stools or nausea"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No confusion or sleep reversal"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No ankle swelling"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; blood pressure 122/76, pulse 72; weight 97.2 kg, BMI 29.3"
            },
            {
              "system": "Abdomen",
              "finding": "Soft; no ascites"
            },
            {
              "system": "Skin",
              "finding": "No jaundice"
            },
            {
              "system": "Neurological",
              "finding": "No asterixis"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-005",
              "display": "Compensated cirrhosis from MASLD",
              "assessment": "Six-month surveillance ultrasound shows no focal lesion and AFP is 4.0 ng/mL. Albumin 4.1 g/dL, bilirubin 0.8 mg/dL and platelets 140; still Child-Pugh A. AST 38 and ALT 31 U/L after weight loss; FIB-4 3.12. Surveillance has been on time, which is what gives the best chance of finding a liver cancer early, when it can be cured",
              "plan": [
                "Next ultrasound with AFP in six months",
                "Results sent to Dr. Deshpande, who reviewed them and agrees; hepatology visit with repeat elastography at one year",
                "Repeat endoscopy in two years"
              ]
            },
            {
              "problem_id": "PRB-001",
              "display": "Type 2 diabetes",
              "assessment": "A1c 6.8%, at goal, with no low blood sugar. Urine albumin-to-creatinine ratio 14 mg/g; creatinine 1.06 mg/dL, eGFR 78",
              "plan": [
                "Continue semaglutide 1 mg weekly and metformin",
                "A1c every six months now that he is at goal"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Hypertension",
              "assessment": "At goal; potassium 4.5 on lisinopril",
              "plan": [
                "Continue the current medicines; kidney tests and potassium in six months"
              ]
            },
            {
              "problem_id": "PRB-007",
              "display": "Obesity",
              "assessment": "6.5% weight loss; BMI now 29.3",
              "plan": [
                "Continue toward 7 to 10%"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "imaging",
              "measure": "Liver ultrasound with AFP for hepatocellular carcinoma surveillance",
              "cadence": "Every 6 months in cirrhosis",
              "status": "completed_today",
              "detail": "Ultrasound: no focal lesion, no ascites, visualization score A; AFP 4.0 ng/mL; on schedule six months after the baseline",
              "observation_ids": [
                "OBS-AFP-V5"
              ],
              "guideline_ids": [
                "GL-AASLD-HCC-2023"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Liver function (albumin, bilirubin, INR, platelets; Child-Pugh and MELD)",
              "cadence": "At diagnosis, then every 6 months",
              "status": "completed_today",
              "detail": "Albumin 4.1, bilirubin 0.8, platelets 140; Child-Pugh A",
              "observation_ids": [
                "OBS-ALB-V5",
                "OBS-TBIL-V5",
                "OBS-PLT-V5"
              ],
              "guideline_ids": [
                "GL-AASLD-HCC-2023",
                "GL-BAVENO-VII"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Liver tests with FIB-4",
              "cadence": "Yearly with diabetes; FIB-4 1.3 or higher leads to elastography",
              "status": "completed_today",
              "detail": "AST 38, ALT 31 U/L; FIB-4 3.12",
              "observation_ids": [
                "OBS-AST-V5",
                "OBS-ALT-V5"
              ],
              "guideline_ids": [
                "GL-AASLD-MASLD-2023",
                "GL-ADA-COMORB-2026"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Transient elastography",
              "cadence": "When FIB-4 is 1.3 or higher; repeat in 1 to 2 years",
              "status": "due",
              "detail": "Repeat at one year",
              "guideline_ids": [
                "GL-AASLD-MASLD-2023",
                "GL-ADA-COMORB-2026"
              ]
            },
            {
              "domain": "referral",
              "measure": "Variceal screening",
              "cadence": "Endoscopy when portal hypertension cannot be ruled out; repeat in 2 years if no varices and the liver injury continues",
              "status": "up_to_date",
              "detail": "No varices in April; repeat in two years",
              "guideline_ids": [
                "GL-BAVENO-VII"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Hemoglobin A1c",
              "cadence": "Every 3 months until at goal or after a change in treatment, then every 6 months",
              "status": "completed_today",
              "detail": "6.8%, at goal",
              "observation_ids": [
                "OBS-A1C-V5"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-ADA-PHARM-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Blood pressure (clinic and home), weight and BMI",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "122/76 in the clinic; home average 124/78; weight 97.2 kg",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-AHA-HTN-2025"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Potassium, creatinine and eGFR (CKD-EPI 2021) on lisinopril",
              "cadence": "Every 6 months on an ACE inhibitor, and after changes",
              "status": "completed_today",
              "detail": "Sodium 140, potassium 4.5, creatinine 1.06 mg/dL, eGFR 78",
              "observation_ids": [
                "OBS-NA-V5",
                "OBS-K-V5",
                "OBS-CR-V5",
                "OBS-EGFR-V5"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-ADA-CKD-2026",
                "GL-CMID-2026",
                "GL-AHA-HTN-2025"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Urine albumin-to-creatinine ratio",
              "cadence": "Yearly",
              "status": "completed_today",
              "detail": "14 mg/g",
              "observation_ids": [
                "OBS-UACR-V5"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-ADA-CKD-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Dilated eye examination",
              "cadence": "At the start of care, then every 1 to 2 years; promptly when A1c is falling quickly on a GLP-1 receptor agonist",
              "status": "up_to_date",
              "detail": "Dilated examination in June: no diabetic retinopathy",
              "guideline_ids": [
                "GL-ADA-RETFOOT-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Comprehensive foot examination",
              "cadence": "Yearly",
              "status": "up_to_date",
              "detail": "At intake; next in February",
              "guideline_ids": [
                "GL-ADA-RETFOOT-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Lipid panel",
              "cadence": "4 to 12 weeks after starting a statin, then yearly",
              "status": "up_to_date",
              "detail": "LDL 68 mg/dL in April; yearly",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-ADA-CVD-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Vitamin B12 on long-term metformin",
              "cadence": "Periodically on long-term metformin",
              "status": "up_to_date",
              "detail": "340 pg/mL at intake",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-ADA-PHARM-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Aspirin for primary prevention",
              "cadence": "Yearly",
              "status": "not_indicated",
              "detail": "Bleeding risk with cirrhosis outweighs benefit in primary prevention",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-ADA-CVD-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Semaglutide dose steps, nausea, abdominal pain, gallbladder and pancreatitis symptoms",
              "cadence": "At each dose step",
              "status": "completed_today",
              "detail": "1 mg weekly; no side effects",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-ADA-PHARM-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Alcohol abstinence",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No alcohol since March",
              "guideline_ids": [
                "GL-AASLD-MASLD-2023",
                "GL-ADA-COMORB-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Warning signs of decompensation (swelling, confusion, bleeding, jaundice)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Reviewed; none",
              "guideline_ids": [
                "GL-AASLD-HCC-2023",
                "GL-BAVENO-VII"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Vaccines for diabetes and chronic liver disease",
              "cadence": "As due",
              "status": "completed_today",
              "detail": "Hepatitis A dose 2, second zoster dose, influenza, COVID-19 and RSV vaccines today",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            }
          ],
          "follow_up": "Visit in three months. Ultrasound with AFP in six months; hepatology visit with elastography at one year. A1c every six months. Colonoscopy next month. Preventive visit in one year",
          "guideline_ids": [
            "GL-AASLD-HCC-2023",
            "GL-AASLD-MASLD-2023",
            "GL-BAVENO-VII",
            "GL-ADA-PHARM-2026",
            "GL-ADA-CKD-2026",
            "GL-AHA-HTN-2025",
            "GL-CDC-IMZ-2026",
            "GL-CMID-2026"
          ]
        }
      },
      {
        "id": "ENC-006",
        "display": "Periodic adult preventive visit",
        "status": "finished",
        "date": "2026-07-13",
        "visit_type": "preventive_adult",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "86013001",
          "display": "Periodic reevaluation and management of healthy individual",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "Periodic adult preventive visit",
          "billing_note": "CPT 99396 (periodic preventive medicine, established patient, age 40 to 64) with CPT 99497 (advance care planning), both on the same day",
          "health_risk_assessment_method": "Completed by the patient with the medical assistant reading the questions aloud, because he reads with one eye, and reviewed with him by Dr. Whitfield",
          "hpi": {
            "narrative": "Mr. Frazier is a 64-year-old former professional heavyweight boxer who runs a boxing gym, with type 2 diabetes, hypertension, hyperlipidemia, obesity, and compensated cirrhosis from MASLD found this spring, who comes for his yearly preventive visit eight weeks after his three-month review. He takes semaglutide 1 mg weekly, metformin, lisinopril, amlodipine 10 mg and atorvastatin without missed doses. His home blood pressure readings average 126/78. He has lost 5.4 kg since intake and has had no alcohol since the liver results. He had the dilated eye examination three weeks ago after missing the first appointment. He asked again whether the blows he took in the ring will affect his memory; today's cognitive screen was done for that reason. He has no new symptoms.",
            "elements": [
              {
                "label": "Visit",
                "value": "Periodic adult preventive visit, age 64"
              },
              {
                "label": "Diabetes",
                "value": "A1c 7.3% at three months; semaglutide 1 mg weekly"
              },
              {
                "label": "Blood pressure",
                "value": "Home average 126/78"
              },
              {
                "label": "Liver",
                "value": "Compensated cirrhosis from MASLD; next surveillance ultrasound and AFP in September"
              },
              {
                "label": "Mood and memory",
                "value": "PHQ-2 1; MoCA 26 today"
              }
            ]
          },
          "health_risk_assessment": [
            {
              "domain": "Self-rated health",
              "finding": "Good, and better since the spring"
            },
            {
              "domain": "Psychosocial",
              "finding": "Busy and proud of his fighters; money is tight; has people he can rely on"
            },
            {
              "domain": "Substance use",
              "finding": "No alcohol since the spring; never used tobacco"
            },
            {
              "domain": "Physical activity",
              "finding": "On his feet at the gym most days; walks after dinner"
            },
            {
              "domain": "Nutrition",
              "finding": "Smaller portions on semaglutide; less fried food and salt"
            },
            {
              "domain": "Sleep",
              "finding": "Seven hours; snores at times; no witnessed pauses in breathing; not sleepy in the day"
            },
            {
              "domain": "Hearing",
              "finding": "No difficulty in conversation"
            },
            {
              "domain": "Vision",
              "finding": "Reads with his right eye; left eye poor for years"
            },
            {
              "domain": "Falls and safety",
              "finding": "No falls; keeps the gym floor clear; wears a seat belt"
            },
            {
              "domain": "Activities of daily living",
              "finding": "Independent"
            },
            {
              "domain": "Memory",
              "finding": "No trouble with appointments, money or medicines; he worries about the future"
            }
          ],
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "No fever; weight down by design"
            },
            {
              "system": "Eyes",
              "status": "negative",
              "finding": "No new change in vision"
            },
            {
              "system": "Ears, nose, mouth, and throat",
              "status": "negative",
              "finding": "No hearing loss or gum bleeding"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No chest pain, palpitations or ankle swelling"
            },
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "No cough or breathlessness"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "No black stools, vomiting of blood, abdominal swelling or yellowing; mild nausea in the first weeks of each semaglutide step, now gone"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "No trouble passing urine; gets up once at night"
            },
            {
              "system": "Musculoskeletal",
              "status": "positive",
              "finding": "Aching knees after long days; no joint swelling"
            },
            {
              "system": "Integumentary",
              "status": "negative",
              "finding": "No foot sores"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No headaches, tremor, numbness or unsteadiness"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood good; PHQ-2 1; no confusion, irritability or change in personality noticed by him or reported to him"
            }
          ],
          "exam": [
            {
              "system": "Constitutional",
              "finding": "Well; weight 98.6 kg, BMI 29.8; blood pressure 124/76; pulse 72"
            },
            {
              "system": "Eyes",
              "finding": "Right eye 20/30; left eye counting fingers at 1 meter, unchanged"
            },
            {
              "system": "Ears",
              "finding": "Whispered-voice test normal on both sides"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm; no murmur; no ankle edema"
            },
            {
              "system": "Respiratory",
              "finding": "Clear to auscultation"
            },
            {
              "system": "Abdomen",
              "finding": "Soft; spleen tip not felt; no ascites; no tenderness"
            },
            {
              "system": "Skin",
              "finding": "No jaundice, spider angiomas or foot sores"
            },
            {
              "system": "Neurological",
              "finding": "Alert and fluent; no tremor or asterixis; gait steady; normal finger-to-nose and rapid alternating movements"
            },
            {
              "system": "Psychiatric",
              "finding": "Good-humored and engaged"
            }
          ],
          "assessment_plan": [
            {
              "display": "Periodic adult preventive visit completed",
              "assessment": "Health risk assessment reviewed and the prevention plan updated. Colorectal cancer screening is due; he chose PSA screening after a discussion of benefits and harms. Montreal Cognitive Assessment 26 of 30, within the normal range, with no difficulty in daily function. Chronic traumatic encephalopathy cannot be diagnosed during life, so no such label is given; the plan is to protect brain health and repeat the screen in a year or sooner if he or those around him notice changes",
              "plan": [
                "Colonoscopy ordered",
                "PSA drawn today",
                "Next preventive visit in one year with a repeat MoCA"
              ]
            },
            {
              "problem_id": "PRB-005",
              "display": "Compensated cirrhosis from MASLD",
              "assessment": "No sign of decompensation. Six-month surveillance ultrasound and AFP due in September",
              "plan": [
                "Liver ultrasound with AFP at the seven-month visit",
                "No alcohol; no NSAIDs"
              ]
            },
            {
              "problem_id": "PRB-001",
              "display": "Type 2 diabetes",
              "assessment": "Improving; eye examination done three weeks ago, with no diabetic retinopathy in the right eye and no retinopathy seen in the left",
              "plan": [
                "A1c at the seven-month visit"
              ]
            }
          ],
          "prevention_plan": [
            {
              "service": "Blood pressure screening",
              "status": "completed_today",
              "detail": "124/76 mmHg; home average 126/78",
              "guideline_ids": [
                "GL-AHA-HTN-2025"
              ]
            },
            {
              "service": "Colorectal cancer screening",
              "status": "ordered",
              "detail": "Last colonoscopy more than ten years ago and normal; colonoscopy ordered, with anesthesia aware of his cirrhosis",
              "guideline_ids": [
                "GL-USPSTF-CRC-2021"
              ]
            },
            {
              "service": "Prostate cancer screening",
              "status": "ordered",
              "detail": "Shared decision for men 55 to 69, discussing his higher risk as a Black man; he chose a PSA test, drawn today",
              "guideline_ids": [
                "GL-USPSTF-PROSTATE-2018"
              ]
            },
            {
              "service": "Lung cancer screening",
              "status": "not_indicated",
              "detail": "Never smoked",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Hepatitis C, hepatitis B and HIV screening",
              "status": "up_to_date",
              "detail": "Nonreactive at intake; vaccinated against hepatitis B",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Depression screening",
              "status": "completed_today",
              "detail": "PHQ-2 1",
              "guideline_ids": [
                "GL-USPSTF-DEP-2023",
                "GL-CMID-2026"
              ]
            },
            {
              "service": "Unhealthy alcohol use",
              "status": "up_to_date",
              "detail": "AUDIT-C 2 at intake; no alcohol since the liver diagnosis",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Cognitive screening",
              "status": "completed_today",
              "detail": "MoCA 26, within the normal range; asked for by him because of his career",
              "guideline_ids": [
                "GL-NINDS-TES-2021",
                "GL-CMID-2026"
              ]
            },
            {
              "service": "Diabetic eye examination",
              "status": "up_to_date",
              "detail": "Dilated examination three weeks ago; next in one year",
              "guideline_ids": [
                "GL-ADA-RETFOOT-2026"
              ]
            },
            {
              "service": "Diabetic foot examination",
              "status": "up_to_date",
              "detail": "At intake; next in one year",
              "guideline_ids": [
                "GL-ADA-RETFOOT-2026"
              ]
            },
            {
              "service": "Statin therapy",
              "status": "up_to_date",
              "detail": "Atorvastatin 40 mg; LDL 68 mg/dL",
              "guideline_ids": [
                "GL-ADA-CVD-2026"
              ]
            },
            {
              "service": "Liver cancer surveillance",
              "status": "due",
              "detail": "Ultrasound with AFP every six months; next in September",
              "guideline_ids": [
                "GL-AASLD-HCC-2023"
              ]
            },
            {
              "service": "Recombinant zoster vaccine",
              "status": "completed_today",
              "detail": "Dose 1 today; dose 2 in two to six months",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Pneumococcal vaccine",
              "status": "up_to_date",
              "detail": "PCV20 in March",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Hepatitis A and B vaccines",
              "status": "due",
              "detail": "Hepatitis B series complete; hepatitis A dose 2 in September",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Tetanus, diphtheria, and pertussis",
              "status": "up_to_date",
              "detail": "Tdap at intake",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Influenza, COVID-19 and RSV vaccines",
              "status": "due",
              "detail": "At the September visit; RSV vaccine recommended because of his age, diabetes and chronic liver disease",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Aspirin for primary prevention",
              "status": "not_indicated",
              "detail": "Bleeding risk with cirrhosis outweighs benefit",
              "guideline_ids": [
                "GL-ADA-CVD-2026"
              ]
            }
          ],
          "advance_care_planning": "Voluntary advance care planning discussion of about 18 minutes, with his consent. He named a health care agent, and a health care proxy form was completed; the agent is recorded in the chart and is not named here. He said that what matters most to him is staying independent and keeping his gym open for the young fighters. He chose not to record specific treatment preferences today and would like to talk again after his next liver checks. The plan will be revisited yearly or after any serious illness.",
          "follow_up": "Seven-month review in nine weeks with the surveillance ultrasound and AFP, A1c, kidney tests, the second zoster dose and the autumn vaccines. PSA result by phone. Colonoscopy to be scheduled. Next preventive visit in one year",
          "guideline_ids": [
            "GL-PREV-2026",
            "GL-USPSTF-AB",
            "GL-CDC-IMZ-2026",
            "GL-CMID-2026",
            "GL-NINDS-TES-2021",
            "GL-AASLD-HCC-2023"
          ]
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic periodic preventive visit.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      }
    ],
    "vital_sign_sets": [
      {
        "id": "VSET-001",
        "date": "2026-02-16",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 182,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 104.0,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 31.4,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 152,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 92,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 76,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.7,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 97,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs, average of two readings with a large adult cuff; no measurement from his life is used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "VSET-002",
        "date": "2026-03-02",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 182,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 103.6,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 31.3,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 148,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 90,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 74,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 97,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs, average of two readings with a large adult cuff; no measurement from his life is used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "VSET-003",
        "date": "2026-04-13",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 182,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 101.8,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 30.7,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 134,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 82,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 72,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.7,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs, average of two readings with a large adult cuff; no measurement from his life is used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "VSET-004",
        "date": "2026-05-18",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 182,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 99.9,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 30.2,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 126,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 78,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 74,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs, average of two readings with a large adult cuff; no measurement from his life is used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "VSET-005",
        "date": "2026-09-14",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 182,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 97.2,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 29.3,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 122,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 76,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 72,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.7,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs, average of two readings with a large adult cuff; no measurement from his life is used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "VSET-006",
        "date": "2026-07-13",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 182,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 98.6,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 29.8,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 124,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 76,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 72,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs at the preventive visit.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      }
    ],
    "social_history": [
      {
        "id": "SOC-001",
        "display": "Former professional heavyweight boxer and Olympic champion; owns and runs a boxing gym in Philadelphia, where he trains young fighters most days",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003",
            "CLM-0005",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic modern work history anchored to his documented career and gym.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "SOC-002",
        "display": "Grew up on a farm in South Carolina; moved to Philadelphia as a teenager and worked in a slaughterhouse",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0001",
            "CLM-0002"
          ],
          "synthetic_reason": "Synthetic modern social history anchored to his documented early life.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "SOC-003",
        "display": "Money is tight; worries about the cost of medicines and appointments; prefers generics and 90-day supplies",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic cost concern anchored to his documented financial trouble.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "SOC-004",
        "display": "Alcohol: one or two beers on some weekends (AUDIT-C 2); no other drug use",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic entry; his real use was not researched and is not used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "SOC-005",
        "display": "Tobacco: never",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic entry.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "SOC-006",
        "display": "Activity: on his feet at the gym most of the day and holds pads for his fighters; no longer runs because of his knees",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic activity history.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "SOC-007",
        "display": "Strengths: discipline, pride in his work, the young fighters who rely on him, his faith, and a long habit of showing up",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic strengths; no person is named.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      }
    ],
    "functional_status": [
      {
        "id": "FUNC-001",
        "display": "Independent in all activities; walks without an aid; reads with his right eye",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004"
          ],
          "synthetic_reason": "Synthetic functional status anchored to the documented left-eye cataract.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      }
    ],
    "mental_status": [
      {
        "id": "MSE-001",
        "display": "Alert, direct and good-humored; oriented; fluent conversation with good recall of recent events; PHQ-9 score 4",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic mental-status finding; not a claim about his real mood or cognition.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      }
    ],
    "consultation": {
      "referral": {
        "question": "High FIB-4 (3.43) with a mildly raised AST and low platelets at the yearly liver check in a 64-year-old man with type 2 diabetes, hypertension, low HDL, high triglycerides and obesity, who drinks little. Please stage his liver disease with elastography and advise on surveillance and treatment",
        "urgency": "Within two weeks, with elastography and an ultrasound the same day",
        "pertinent_history": "Former professional heavyweight boxer who runs a gym. Type 2 diabetes for about twelve years on metformin (A1c 8.4%); hypertension on lisinopril, above goal; LDL 132 mg/dL, HDL 38, triglycerides 210; BMI 31.4. Alcohol: one or two beers on some weekends (AUDIT-C 2); never smoked; no drug use. No history of jaundice, swelling or bleeding. Today: AST 48 and ALT 42 U/L, alkaline phosphatase 96, albumin 4.0 g/dL, bilirubin 0.9 mg/dL, platelets 138, hemoglobin 14.2, creatinine 1.08 mg/dL (eGFR 77), urine albumin-to-creatinine ratio 18 mg/g. FIB-4 3.43. Atorvastatin 40 mg started today. Hepatitis B, hepatitis C and HIV tests, iron studies and autoimmune tests sent. Reduced vision in the left eye since a cataract found at 20",
        "questions": [
          "How advanced is the fibrosis, and is this MASLD?",
          "Does he need liver cancer surveillance, and how often?",
          "Does he need screening for varices or a beta-blocker?",
          "Which diabetes medicine would you favor for his liver, and are metformin and atorvastatin safe?",
          "Which vaccines and other precautions do you advise?"
        ]
      },
      "consultant_note": {
        "history": "Mr. Frazier, a 64-year-old former professional boxer, is seen at the request of Dr. Whitfield for a FIB-4 of 3.43 found at his yearly diabetes check. He feels well and has had no jaundice, abdominal or leg swelling, black stools, vomiting of blood or confusion. He drinks one or two beers on some weekends and has never drunk heavily. He has had diabetes for about twelve years and high blood pressure for many years. He has never had a blood transfusion or used injected drugs. He wants to keep working at his gym",
        "data_reviewed": "Dr. Whitfield's intake note and results: AST 48, ALT 42 U/L, alkaline phosphatase 96, albumin 4.0 g/dL, bilirubin 0.9 mg/dL, platelets 138, creatinine 1.08 mg/dL, FIB-4 3.43. Today: transient elastography with a median liver stiffness of 17.6 kPa (interquartile range 14%) and a controlled attenuation parameter of 318 dB/m; ultrasound with a coarse, echogenic, mildly nodular liver, a spleen of 13.4 cm, a patent portal vein, no ascites and no focal lesion; INR 1.1; AFP 4.2 ng/mL. Hepatitis B surface antigen, core antibody and surface antibody negative; hepatitis A antibody negative; hepatitis C antibody and HIV nonreactive; ferritin and transferrin saturation normal; antinuclear and smooth muscle antibodies negative",
        "exam": [
          {
            "system": "General",
            "finding": "Well; blood pressure 148/90, pulse 74; BMI 31.3"
          },
          {
            "system": "Abdomen",
            "finding": "Liver edge firm at the costal margin; spleen tip not felt; no ascites"
          },
          {
            "system": "Skin",
            "finding": "No jaundice, spider angiomas or palmar erythema"
          },
          {
            "system": "Neurological",
            "finding": "No asterixis"
          }
        ],
        "assessment": [
          {
            "problem_id": "PRB-004",
            "display": "Metabolic dysfunction-associated steatotic liver disease",
            "assessment": "Steatosis with diabetes, obesity, low HDL and high triglycerides and little alcohol meets the definition of MASLD. Other causes have been excluded by the tests above"
          },
          {
            "problem_id": "PRB-005",
            "display": "Compensated cirrhosis",
            "assessment": "A FIB-4 above 2.67 followed by a liver stiffness of 17.6 kPa, with platelets of 138, a nodular liver and a large spleen, is consistent with compensated advanced chronic liver disease, most likely cirrhosis. A biopsy would not change management. Child-Pugh A (5 points), MELD 8. There is no sign of decompensation"
          },
          {
            "problem_id": "PRB-005",
            "display": "Liver cancer surveillance",
            "assessment": "Cirrhosis from MASLD carries a risk of hepatocellular carcinoma high enough to justify surveillance by ultrasound with AFP every six months; today's baseline is clear and of good quality. Surveillance on time is what finds cancer when it can still be cured"
          },
          {
            "problem_id": "PRB-005",
            "display": "Portal hypertension",
            "assessment": "A stiffness between 15 and 25 kPa with platelets below 150 cannot rule clinically significant portal hypertension in or out, so an upper endoscopy to look for varices is advised; a beta-blocker would be started if varices needing treatment are found"
          },
          {
            "problem_id": "PRB-001",
            "display": "Diabetes and the liver",
            "assessment": "A GLP-1 receptor agonist such as semaglutide is favored: it lowers glucose and weight, has cardiovascular and kidney benefit, and improves steatohepatitis. Metformin is safe to continue in compensated cirrhosis with normal kidney function, and atorvastatin is safe and beneficial. Sulfonylureas and insulin are not needed and carry a risk of low blood sugar"
          }
        ],
        "recommendations": [
          "Liver ultrasound with AFP every six months, starting with today's baseline",
          "Upper endoscopy to screen for varices within the next six weeks; if none are found and the liver injury continues, repeat in two years",
          "Start semaglutide and increase it as tolerated; continue metformin and atorvastatin 40 mg",
          "Aim for 7 to 10% weight loss over a year",
          "No alcohol at all; no ibuprofen or naproxen; acetaminophen no more than 2 g a day",
          "Hepatitis A and B vaccine series and PCV20 now; influenza, COVID-19 and RSV vaccines in season",
          "Albumin, bilirubin, platelets and kidney function every six months; repeat elastography in one year",
          "Teach the warning signs of decompensation: abdominal or leg swelling, black stools or vomiting of blood, confusion, yellowing"
        ],
        "communication": "Discussed with Dr. Whitfield, who saw him the same day. The diagnosis and plan were explained to Mr. Frazier, who agreed and asked for a written list of the warning signs, which was given",
        "follow_up": "Hepatology review of the six-month ultrasound and AFP, a visit with repeat elastography at one year, and sooner for any warning sign; Dr. Whitfield continues primary care"
      },
      "guideline_ids": [
        "GL-AASLD-MASLD-2023",
        "GL-AASLD-HCC-2023",
        "GL-BAVENO-VII",
        "GL-ADA-COMORB-2026",
        "GL-ADA-PHARM-2026",
        "GL-CDC-IMZ-2026"
      ]
    }
  },
  "care_plan": {
    "health_concerns": [
      {
        "id": "HC-001",
        "display": "He wants to keep working at his gym and stay strong",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic patient-centered concern.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "HC-002",
        "display": "He worries about the cost of new medicines",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic patient-centered concern.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "HC-003",
        "display": "He wants to know whether the blows he took in the ring will affect his memory",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic patient-centered concern.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      }
    ],
    "goals": [
      {
        "id": "GOAL-001",
        "display": "A1c below 7% within six to nine months, without low blood sugar",
        "status": "completed",
        "target_date": "2026-09-14",
        "outcome": "8.4% to 6.8% at seven months; no low blood sugar",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic diabetes goal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "GOAL-002",
        "display": "Blood pressure below 130/80 mmHg in the clinic and at home",
        "status": "completed",
        "target_date": "2026-09-14",
        "outcome": "122/76 in the clinic; home average 124/78",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood pressure goal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "GOAL-003",
        "display": "LDL cholesterol below 70 mg/dL",
        "status": "completed",
        "target_date": "2026-04-13",
        "outcome": "132 to 68 mg/dL on atorvastatin",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid goal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "GOAL-004",
        "display": "Weight loss of 7 to 10% for liver health within a year",
        "status": "active",
        "target_date": "2026-09-14",
        "outcome": "104.0 to 97.2 kg (6.5%) at seven months",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic weight goal set with him, without stigma.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "GOAL-005",
        "display": "Liver cancer surveillance by ultrasound with AFP every six months, on time",
        "status": "completed",
        "target_date": "2026-09-14",
        "outcome": "Baseline and six-month ultrasounds with AFP on schedule; no focal lesion; AFP 4.2 and 4.0 ng/mL",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic surveillance goal; the teaching point of the case.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "GOAL-006",
        "display": "No alcohol, to protect the liver",
        "status": "completed",
        "target_date": "2026-09-14",
        "outcome": "No alcohol since the two-week visit",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic alcohol goal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      }
    ],
    "interventions": [
      {
        "id": "INT-001",
        "display": "Diabetes: continue metformin, an A1c every three months until at goal and then every six months, diabetes self-management education, a vitamin B12 check on long-term metformin, and no medicine that causes low blood sugar",
        "status": "completed",
        "guideline_ids": [
          "GL-ADA-PHARM-2026",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic diabetes plan.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "INT-002",
        "display": "Hepatology consultation for a high FIB-4 with mildly low platelets, with transient elastography and a liver ultrasound the same day",
        "status": "completed",
        "guideline_ids": [
          "GL-AASLD-MASLD-2023",
          "GL-ADA-COMORB-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic specialist consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "INT-003",
        "display": "Liver assessment: FIB-4 from the yearly liver tests, then transient elastography if FIB-4 is 1.3 or higher; hepatitis B, hepatitis C and HIV tests, iron studies, and an alcohol history",
        "status": "completed",
        "guideline_ids": [
          "GL-AASLD-MASLD-2023",
          "GL-ADA-COMORB-2026",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic liver assessment plan.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "INT-004",
        "display": "Compensated cirrhosis: liver ultrasound with AFP every six months for hepatocellular carcinoma surveillance, upper endoscopy to screen for varices, hepatitis A and B and pneumococcal vaccines, no alcohol, no NSAIDs, acetaminophen no more than 2 g a day, and teaching on the warning signs of decompensation",
        "status": "completed",
        "guideline_ids": [
          "GL-AASLD-HCC-2023",
          "GL-BAVENO-VII",
          "GL-AASLD-MASLD-2023",
          "GL-CDC-IMZ-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic cirrhosis plan decided at the consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        },
        "recorded_date": "2026-03-02"
      },
      {
        "id": "INT-005",
        "display": "Semaglutide once weekly, increased every four to eight weeks as tolerated, for its cardiovascular and kidney benefit, weight and steatotic liver disease; prior authorization and the manufacturer's assistance program handled by the clinic",
        "status": "completed",
        "guideline_ids": [
          "GL-ADA-PHARM-2026",
          "GL-ADA-COMORB-2026",
          "GL-AASLD-MASLD-2023"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic glucose-lowering choice decided at the consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        },
        "recorded_date": "2026-03-02"
      },
      {
        "id": "INT-006",
        "display": "Blood pressure: a validated home monitor with a large cuff, readings twice a day for a week, a goal below 130/80 mmHg, and less salt",
        "status": "completed",
        "guideline_ids": [
          "GL-AHA-HTN-2025",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood pressure plan.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "INT-007",
        "display": "Amlodipine added to lisinopril and increased to reach the goal, with ankle-swelling checks",
        "status": "completed",
        "guideline_ids": [
          "GL-AHA-HTN-2025",
          "GL-ADA-CVD-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic medication step decided from the home readings.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        },
        "recorded_date": "2026-03-02"
      },
      {
        "id": "INT-008",
        "display": "Cardiovascular risk: atorvastatin 40 mg with a lipid panel at four to twelve weeks; a baseline ECG; aspirin for primary prevention not used because of bleeding risk",
        "status": "completed",
        "guideline_ids": [
          "GL-ADA-CVD-2026",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic cardiovascular plan.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "INT-009",
        "display": "Kidneys: eGFR by the race-free CKD-EPI 2021 equation and urine albumin-to-creatinine ratio at least yearly, and potassium and creatinine on lisinopril",
        "status": "completed",
        "guideline_ids": [
          "GL-ADA-CKD-2026",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic kidney plan.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "INT-010",
        "display": "Eyes and feet: a dilated eye examination at the eye clinic, a comprehensive foot examination yearly, daily foot checks and callus care",
        "status": "completed",
        "guideline_ids": [
          "GL-ADA-RETFOOT-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004"
          ],
          "synthetic_reason": "Synthetic eye and foot plan.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "INT-011",
        "display": "Brain health: a documented cognitive screen at the preventive visit, blood pressure and glucose control, sleep, hearing and mood checks, and an honest conversation that chronic traumatic encephalopathy cannot be diagnosed during life",
        "status": "completed",
        "guideline_ids": [
          "GL-NINDS-TES-2021",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic brain-health plan.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      },
      {
        "id": "INT-012",
        "display": "Cost and access: low-cost generics, 90-day supplies, and help with coverage for any brand-name medicine",
        "status": "completed",
        "guideline_ids": [
          "GL-ADA-POP-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic access plan.",
          "author": "The Human Record generator",
          "created": "2026-11-04T18:00:00-05:00"
        }
      }
    ],
    "guidelines": [
      {
        "guideline_id": "GL-ADA-PHARM-2026",
        "title": "9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2026",
        "publisher": "American Diabetes Association (Diabetes Care 2026;49(Suppl 1))",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41358900/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-ADA-CVD-2026",
        "title": "10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2026",
        "publisher": "American Diabetes Association (Diabetes Care 2026;49(Suppl 1))",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41358899/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-ADA-COMORB-2026",
        "title": "4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes-2026",
        "publisher": "American Diabetes Association (Diabetes Care 2026;49(Suppl 1))",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41358897/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-ADA-CKD-2026",
        "title": "11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes-2026",
        "publisher": "American Diabetes Association (Diabetes Care 2026;49(Suppl 1))",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41358881/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-ADA-RETFOOT-2026",
        "title": "12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes-2026",
        "publisher": "American Diabetes Association (Diabetes Care 2026;49(Suppl 1))",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41358886/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-ADA-POP-2026",
        "title": "1. Improving Care and Promoting Health in Populations: Standards of Care in Diabetes-2026",
        "publisher": "American Diabetes Association (Diabetes Care 2026;49(Suppl 1))",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41358887/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-AHA-HTN-2025",
        "title": "2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults",
        "publisher": "American Heart Association and American College of Cardiology (J Am Coll Cardiol 2025)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/40815242/",
        "version_or_year": "2025"
      },
      {
        "guideline_id": "GL-AASLD-MASLD-2023",
        "title": "AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease (now metabolic dysfunction-associated steatotic liver disease)",
        "publisher": "American Association for the Study of Liver Diseases (Hepatology 2023;77(5))",
        "url": "https://pubmed.ncbi.nlm.nih.gov/36727674/",
        "version_or_year": "2023"
      },
      {
        "guideline_id": "GL-AASLD-HCC-2023",
        "title": "AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma",
        "publisher": "American Association for the Study of Liver Diseases (Hepatology 2023;78(6))",
        "url": "https://pubmed.ncbi.nlm.nih.gov/37199193/",
        "version_or_year": "2023"
      },
      {
        "guideline_id": "GL-BAVENO-VII",
        "title": "Baveno VII - Renewing consensus in portal hypertension",
        "publisher": "Baveno VII Faculty (Journal of Hepatology 2022;76(4))",
        "url": "https://pubmed.ncbi.nlm.nih.gov/35120736/",
        "version_or_year": "2022"
      },
      {
        "guideline_id": "GL-NINDS-TES-2021",
        "title": "National Institute of Neurological Disorders and Stroke Consensus Diagnostic Criteria for Traumatic Encephalopathy Syndrome",
        "publisher": "Neurology 2021;96(18)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/33722990/",
        "version_or_year": "2021"
      },
      {
        "guideline_id": "GL-CDC-IMZ-2026",
        "title": "Adult Immunization Schedule by Medical Condition and Other Indication",
        "publisher": "Centers for Disease Control and Prevention",
        "url": "https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-medical-condition.html",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-CMID-2026",
        "title": "CMID: Clinical Monitoring Intelligence Database, diabetes type 2, hypertension and hyperlipidemia monographs",
        "publisher": "Aether Forge",
        "url": "https://patrickrutledge.github.io/topthirty/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-PREV-2026",
        "title": "Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements",
        "publisher": "Aether Forge",
        "url": "https://patrickrutledge.github.io/preventative_services/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-AB",
        "title": "USPSTF A and B Recommendations",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/uspstf-a-and-b-recommendations",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-CRC-2021",
        "title": "Colorectal Cancer: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening",
        "version_or_year": "2021"
      },
      {
        "guideline_id": "GL-USPSTF-PROSTATE-2018",
        "title": "Prostate Cancer: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/prostate-cancer-screening",
        "version_or_year": "2018"
      },
      {
        "guideline_id": "GL-USPSTF-DEP-2023",
        "title": "Depression and Suicide Risk in Adults: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-depression-suicide-risk-adults",
        "version_or_year": "2023"
      }
    ]
  },
  "review": {
    "schema_validation": {
      "status": "not_started",
      "notes": "Run scripts/build.ps1 -Conformance."
    },
    "clinical_review": {
      "status": "not_started",
      "notes": "Awaiting clinician review; check the FIB-4 to elastography pathway, the diagnosis of compensated cirrhosis from a liver stiffness of 17.6 kPa with platelets of 138 and ultrasound findings, the endoscopy rather than a beta-blocker, six-monthly ultrasound with AFP, semaglutide with metformin, the eGFR without a race term, amlodipine with lisinopril, aspirin not used, and the cognitive screen without a CTE diagnosis."
    },
    "provenance_review": {
      "status": "not_started",
      "notes": "Sources: an ESPN Classic biography and an ESPN Classic article written during his life, and obituaries from ESPN, the Associated Press (The Philadelphia Inquirer, CBS Los Angeles, The Vindicator) and The Irish Times. A posthumous magazine profile was not used."
    },
    "safe_messaging_review": {
      "status": "not_started",
      "notes": "Recent-death rule: only what was reported publicly during his life or in obituaries and statements by his manager and family. No sick visit. No mental health or substance claim is made. The liver disease, cognitive screen and every clinical finding are synthetic. No living relative is named, and his rival is not named."
    }
  }
}
